Stage FocusSeed, Series A, Series B+
GeographyJapan, US, Global
TypeCVC
Last Activity2025
Industry Focus
Industries
Advanced MaterialsMedtechClimate TechAISpaceBuilt EnvironmentMobility
Technical BenchStrong
Investor TypeCVC
ExposureSome DeepTech Investments
Bio
Mitsui Chemicals operates two CVC vehicles: 321FORCE ($36.8M, managed by Global Brain) and 321Catalyst ($60M, 2025). The 321Catalyst Ventures subsidiary manages Fund II from San Jose, California, with a 10-year fund life.
Focus areas include life/healthcare, mobility, ICT, carbon neutrality, DX, smart cities, and "universe" (space). Investment criteria emphasize synergy with Mitsui Chemicals' ass...
Similar Funds
3M Ventures
St. Paul, United States
GeneralistAdvanced MaterialsClimate TechMedtechSeedSeries A
BASF Venture Capital
Mannheim, Germany
DeepTech NativeAdvanced MaterialsClimate TechAgritechSeedSeries A
Vale Ventures
Rio de Janeiro, Brazil
DeepTech NativeAdvanced MaterialsClimate TechRoboticsSeedSeries A
AC
Alante Capital
Santa Barbara, California, United States
DeepTech NativeAdvanced MaterialsSynthetic BiologyClimate TechPre-SeedSeed
AK
Asahi Kasei Ventures
Menlo Park, United States
Industrial / CVCAdvanced MaterialsBiotechMedtechSeedSeries A
Hitachi Ventures
Tokyo, Japan
DeepTech NativeIoT & EdgeAIQuantumSeedSeries A